Novel combination therapy targeting rDNA transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM

Citation

MacLachlan, K, Cuddihy, A, Hein, N et al 2018, 'Novel combination therapy targeting rDNA transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM', <>, p. 1945.

Year

2018

Field of Research

  • Cancer Cell Biology

Updated:  01 July 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers